MedPath

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY

THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY logo
🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.qduh.cn
Clinical Trials
Related News

Femoral External Rotation Measured on CT and MRI

Conditions
Knee Osteoarthritis
Interventions
Other: CT and MRI
First Posted Date
2022-04-14
Last Posted Date
2022-04-21
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
100
Registration Number
NCT05327413
Locations
🇨🇳

The affiliated hospital of Qingdao University, Qingdao, Shandong, China

Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

Conditions
Rituximab
Blood Disease
Children
Interventions
First Posted Date
2022-04-13
Last Posted Date
2022-04-13
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
20
Registration Number
NCT05324917

PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer

Phase 1
Conditions
Efficacy
Safety
Interventions
Drug: PD-L1 inhibitor
First Posted Date
2022-04-13
Last Posted Date
2022-04-13
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
30
Registration Number
NCT05325684

To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout

Phase 1
Conditions
Gout
Interventions
First Posted Date
2022-04-12
Last Posted Date
2022-05-09
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
20
Registration Number
NCT05324423
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Study on the Human Bioequivalence of Oseltamivir Phosphate For Oral Suspension

First Posted Date
2022-03-28
Last Posted Date
2022-03-28
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
72
Registration Number
NCT05297968
Locations
🇨🇳

Phase I Clinical Research Center, Qingdao, Shandong, China

A Bioequivalence Trial of Irbesartan Tablets（0.15g） in Healthy Chinese Subjects

Phase 1
Conditions
Under Fed Condition
Under Fasted Condition
Irbesartan Tablets (0.15g/Tablet)
Bioequivalence
Interventions
First Posted Date
2022-03-28
Last Posted Date
2022-03-28
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
54
Registration Number
NCT05297929
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

Conditions
Liver Fibrosis After Liver Transplantation
Multiparameter Magnetic Resonance Imaging
First Posted Date
2022-03-23
Last Posted Date
2022-03-23
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
40
Registration Number
NCT05292885
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques

Not yet recruiting
Conditions
Proteomics
Prognostic Biomarkers
Pancreatic Cancer
Interventions
Other: No intervention
First Posted Date
2022-03-22
Last Posted Date
2022-03-22
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
220
Registration Number
NCT05289895

Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL

Not Applicable
Conditions
Diffuse Large B Cell Lymphoma
Interventions
Other: Autologous anti-CD19 CAR-T cell injection
First Posted Date
2022-03-08
Last Posted Date
2022-03-08
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
10
Registration Number
NCT05269914

18F-FAPI PET in the Diagnosis of Liver Fibrosis

Conditions
Positron Emission Tomography
FAP
Liver Fibrosis
First Posted Date
2022-03-02
Last Posted Date
2022-03-02
Lead Sponsor
The Affiliated Hospital of Qingdao University
Target Recruit Count
40
Registration Number
NCT05262647
Locations
🇨🇳

The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy